跳至主要内容
临床试验/CTRI/2019/02/017690
CTRI/2019/02/017690招募中3 期

A randomized single blind, placebo control clinical study to evaluate the efficacy of Dalbergia sissoo extract (Dalzbone capsule) in healing of diaphyseal fracture of femur - DSFFCT

Pharmanza Herbal Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Radiologically diagnosed traumatic diaphyseal fracture of femur bone indifferent of compound, comminuted, closed or open fracture with surgical intervention.
  • 2. Willing to give informed consent.
  • 3. 0-5 days from the incident of fracture.

排除标准

  • 1. Pathological fracture.
  • 2. Fracture patients with uncontrolled HTN(Blood Pressure >=140 mmHg or an average Diastolic Blood Pressure >=90 mmHg among those with HTN) or diabetes (Blood Glucose Level > 200 and Fasting Blood Glucose Level > 125 among those with diabetes)
  • 3. Fracture in smokers.
  • 4. Pregnant and breast feeding women.
  • 5. History of allergy to herbal medicines.
  • 6. Patient with renal failure, liver failure and or cardiac failure.

研究者

相似试验